Phase 3 Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have previously tried a structured weight loss program (including diet and exercise guidance for at least 3 months) without losing enough weight.
- People aged 12 to under 18 whose BMI is at or above the 95th percentile for their age and sex, which is considered obesity according to CDC growth charts.
- People aged 12 to under 18 whose BMI is between the 85th and 95th percentile for their age and sex (considered overweight), AND who also have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, prediabetes, abnormal cholesterol levels, obstructive sleep apnea, or certain liver conditions (MASH or MASLD).
Who may not be able to join:
- People who have already had, or are planning to have, weight loss surgery during the study — such as gastric bypass, sleeve gastrectomy, or gastric banding procedures.
- People whose obesity is caused by an underlying medical condition, such as a hormonal disorder, a genetic syndrome, or a brain-related cause.
- People who have lost more than 5 kg (11 lbs) in the 90 days before the screening appointment, as reported by themselves, or by a parent or legal guardian where applicable.
- People who have type 1 diabetes, or a history of a serious blood sugar crisis called ketoacidosis or hyperosmolar state.
- People whose blood sugar control measurement (HbA1c) is above 9.0% at screening, as tested by the trial's laboratory.
- People who have a personal or family history of a type of thyroid cancer called medullary thyroid carcinoma, or a condition called Multiple Endocrine Neoplasia Syndrome Type 2.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company
Phone: 1-317-615-4559
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants Allocated to Each ISA
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.